PLATELET SUPPRESSION BY TIROFIBAN AMELIORATES PULMONARY COAGULATION AND FIBRINOLYSIS ABNORMALITIES IN THE LUNGS OF MOUSE ANTIBODY-MEDIATED TRANSFUSION-RELATED ACUTE LUNG INJURY

被引:3
|
作者
Yuan, Xin [1 ]
Jiang, Peng [1 ]
Qiao, CongChao [1 ]
Su, Na [1 ]
Sun, Pan [1 ]
Lin, Fangzhao [1 ,2 ]
Li, Changqing [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, Chengdu, Sichuan, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Blood Transfus, Chengdu 610052, Sichuan, Peoples R China
来源
SHOCK | 2023年 / 59卷 / 04期
关键词
Coagulation; fibrinolytic; tirofiban; transfusion-related acute lung injury (TRALI); DEPOSITION; PROCOAGULANT; INFLAMMATION; ACTIVATION; EXPRESSION; PATHWAYS; SUPPORT; LAVAGE;
D O I
10.1097/SHK.0000000000002080
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
This study aimed to explore the ameliorating effects of the platelet surface glycoprotein IIb/IIIa receptor antagonist tirofiban on coagulation and fibrinolytic abnormalities in a mouse model of antibody-mediated transfusion-associated acute lung injury (ALI). This is important because ALI is a major cause of death attributable to the occurrence of adverse transfusion reactions. No information on a definite diagnosis or pathological mechanism exists, and targeted treatment options are not available. In this study, wild-type male Balb/c mice aged 8 to 10 weeks were randomly divided into the TRALI model, blank control, tirofiban intervention, and isotype control groups. After different treatment exposures, the mice were observed for 2 h before being killed, and lung tissue samples were collected. To explore the intervention effect of tirofiban, the degree of lung injury was quantified by estimating the lung wet/dry ratio, rectal temperature, survival rate, total protein, and myeloperoxidase and via hematoxylin-eosin staining. Furthermore, the coagulation, anticoagulation, and fibrinolysis assays were measured by automatic coagulation instrument and enzyme-linked immunosorbent assay kits, and the fluorescence densities of platelets and fibrin were quantified using immunofluorescence to analyze the effects of tirofiban on the platelet and fibrin interactions of TRALI. Compared with the TRALI model group, the lung injury indices in the tirofiban intervention group decreased significantly, and survival rates also improved. Furthermore, the level of coagulation and fibrinolytic abnormalities were obviously lower than those in the TRALI model group. In conclusion, our findings suggest that tirofiban might interfere with TRALI by inhibiting platelet activation and improving coagulation and fibrinolytic abnormalities.
引用
收藏
页码:603 / 611
页数:9
相关论文
共 50 条
  • [1] Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury
    Yu, Yunhong
    Jiang, Peng
    Sun, Pan
    Su, Na
    Lin, Fangzhao
    MOLECULAR MEDICINE REPORTS, 2021, 24 (02)
  • [2] Antibody-mediated transfusion-related acute lung injury
    Bux, Juergen
    TRANSFUSION, 2006, 46 (08) : 1455 - 1455
  • [3] Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse
    Hechler, B.
    Maitre, B.
    Magnenat, S.
    Heim, V
    El Mdawar, M-B
    Gachet, C.
    de la Salle, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 110 - 111
  • [4] Platelets are dispensable for antibody-mediated transfusion-related acute lung injury in the mouse
    Hechler, B.
    Maitre, B.
    Magnenat, S.
    Heim, V.
    El Mdawar, M. -B.
    Gachet, C.
    de la Salle, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (06) : 1255 - 1267
  • [5] Antibody-mediated (immune) transfusion-related acute lung injury
    Bux, J.
    VOX SANGUINIS, 2011, 100 (01) : 122 - 128
  • [6] Antibody-mediated transfusion-related acute lung injury; from discovery to prevention
    Peters, Anna L.
    Van Stein, Danielle
    Vlaar, Alexander P. J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (05) : 597 - 614
  • [7] Pancreatic involvement in murine antibody-mediated transfusion-related acute lung injury?
    Kapur, Rick
    Rebetz, Johan
    van Der Velden, Saskia
    Semple, John W.
    TRANSFUSION, 2021, 61 (03) : 987 - 989
  • [8] Recipient T lymphocytes modulate the severity of antibody-mediated transfusion-related acute lung injury
    Fung, Yoke Lin
    Kim, Michael
    Tabuchi, Arata
    Aslam, Rukhsana
    Speck, Edwin R.
    Chow, Leola
    Kuebler, Wolfgang M.
    Freedman, John
    Semple, John W.
    BLOOD, 2010, 116 (16) : 3073 - 3079
  • [9] Recipient Platelet-Derived Extracellular Vesicles (PEV) Suppress Antibody-Mediated Transfusion-Related Acute Lung Injury (TRALI)
    Marcoux, Genevieve
    Rebetz, Johan
    Cederholm, Hilma
    Moore, Ellen
    McGauran, David
    Johansson, Karl
    Semple, John W.
    BLOOD, 2023, 142
  • [10] Non-HLA Antibody-Mediated Rejection of Lung Transplant Masquerading Transfusion-Related Acute Lung Injury
    Yunce, Muharrem
    Virk, Mrigender
    Zhang, Bing M.
    Mooney, Kelly
    Saleem, Atif
    Shan, Hua
    TRANSFUSION, 2019, 59 : 199A - 199A